ArticlePharmacology research & perspectives2021

Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway.

Guolin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.